AriBio's AR1001, a Viagra-like Drug, Shows Promise in Slowing Alzheimer's Progression in Clinical Trials
Rapid Read

AriBio's AR1001, a Viagra-like Drug, Shows Promise in Slowing Alzheimer's Progression in Clinical Trials

What's Happening? AriBio, a South Korean pharmaceutical company, has announced promising results from a Phase 3 clinical trial for its drug AR1001, which is designed to slow the progression of Alzheimer's disease. The drug, a phosphodiesterase-5 inhibitor similar to Viagra, demonstrated a 31% reduct
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.